Regeneron Pharmaceuticals
REGN
NASDAQ
IPO1991
about REGN
Regeneron Pharmaceuticals is a leading biopharmaceutical company focused on researching, developing, and producing innovative medicines and genetic-based treatments, including its widely used treatment for eye diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $754.55 | $758.98 | $741.89 | $78.8B | 438.30K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$14.09 | n/a | n/a | 27.35% | 38.89% | 0% |